16 июл 2012 г. - FDA Approves Truvada
Описание:
On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved the use of Truvada® (a fixed dose combination of emtricitabine/tenofovir disoproxil fumarate) as a pre-exposure prophylaxis (PrEP) for HIV-negative individuals who are at high risk of acquiring HIV.Добавлено на ленту времени:
Дата:
16 июл 2012 г.
Сейчас
~ 12 г назад